These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Prevalence and determinants of pain in chronic inflammatory demyelinating polyneuropathy: Results from the German INHIBIT registry. Mork H; Motte J; Fisse AL; Grüter T; Brünger J; Stoykova Z; Bulut Y; Athanasopoulos D; Sturm D; Tegenthoff M; Gold R; Enax-Krumova E; Pitarokoili K Eur J Neurol; 2022 Jul; 29(7):2109-2120. PubMed ID: 35357725 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes. Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218 [TBL] [Abstract][Full Text] [Related]
12. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Boukhris S; Magy L; Khalil M; Sindou P; Vallat JM J Neurol Sci; 2007 Mar; 254(1-2):33-8. PubMed ID: 17286985 [TBL] [Abstract][Full Text] [Related]
13. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary? Wadwekar V; Kalita J; Misra UK Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647 [TBL] [Abstract][Full Text] [Related]
14. Association of neuropathic-like pain characteristics with clinical and radiographic features in patients with ankylosing spondylitis. Choi JH; Lee SH; Kim HR; Lee KA Clin Rheumatol; 2018 Nov; 37(11):3077-3086. PubMed ID: 29713968 [TBL] [Abstract][Full Text] [Related]
15. Neuropathic pain in patients with Charcot-Marie-Tooth type 1A. Bjelica B; Peric S; Basta I; Bozovic I; Kacar A; Marjanovic A; Ivanovic V; Brankovic M; Jankovic M; Novakovic I; Rakocevic Stojanovic V Neurol Sci; 2020 Mar; 41(3):625-630. PubMed ID: 31729581 [TBL] [Abstract][Full Text] [Related]
16. Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance. Merkies IS; van Nes SI; Hanna K; Hughes RA; Deng C J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1194-9. PubMed ID: 20647554 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus. Kalita J; Misra UK; Yadav RK Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941 [TBL] [Abstract][Full Text] [Related]
18. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy. Klehmet J; Beutner S; Hoffmann S; Dornauer M; Paul F; Reilmann R; Brandt AU; Meisel A BMC Neurol; 2019 Jun; 19(1):118. PubMed ID: 31176377 [TBL] [Abstract][Full Text] [Related]
19. Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Bozovic I; Peric M; Arsic Azanjac A; Palibrk A; Bulatovic I; Aleksic D; Peric S; Basta I Qual Life Res; 2021 Sep; 30(9):2573-2579. PubMed ID: 33830457 [TBL] [Abstract][Full Text] [Related]